NCT01275105
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2011
Completion: Mar 31, 2011